Elmar Schnee, former CEO Merck Serono is joining Calliditas as chairman of the Board along side Diane Parks, who will also be joining the board.
Elmar has served as general partner and member of the Executive Board of Merck KGaA and has held previously several senior global management positions with UCB and Sanofi. He is the chairman of the board of directors of Santhera Pharmaceutical, and member of the board of directors of Jazz Pharmaceuticals and Stallergenes Greer as well as a board director of several private healthcare companies.
Diane Parks is a senior executive with deep sales and marketing experience from the U.S., where she has held positions such as head of US Commercial for Kite Pharma, VP of Sales for Amgen and head of Global Marketing at Pharmacyclics.
“We are excited that two exceptionally experienced professionals are proposed to the Board of Calliditas. With our commercial focus on the US and our strategic intention to build an orphan focused company, we believe that their experience will significantly benefit the company and we look forward to working with them and the rest of the Board to achieve this,” said Renée Aguiar-Lucander, CEO of Calliditas.
